Back to Market Feed

Historical record - last NADAC effective date: 12/22/2017

Product Information

KALETRA 80 MG-20 MG/ML SOLN is a brand product labeled by AbbVie Inc., priced at $3.1186 per ML under NDC 00074395646. Its NADAC has been published 264 times since Nov 28, 2013.

FDA first approved this application on Sep 15, 2000.

KALETRA 80 MG-20 MG/ML SOLN

Lopinavir and Ritonavir
$3.1186per ML

Strength

80; 20 mg/mL; mg/mL

Manufacturer

AbbVie Inc.

NDC

00074395646

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Effective Date

12/22/2017

Active Ingredients

LOPINAVIR; RITONAVIR

Approval Type

New Drug (NDA)

FDA Application

NDA021251

FDA Approved

9/15/2000

On Market Since

6/18/2010

Pharmacological Classes

Breast Cancer Resistance Protein Inhibitors
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inducers
Cytochrome P450 3A Inhibitor
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
HIV Protease Inhibitors
HIV Protease Inhibitors
Organic Anion Transporting Polypeptide 1B1 Inhibitors
P-Glycoprotein Inhibitors
P-Glycoprotein Inhibitors
Protease Inhibitor
Protease Inhibitor
UDP Glucuronosyltransferases Inducers

Price Statistics

The NADAC for KALETRA 80 MG-20 MG/ML SOLN has been published 264 times since Nov 28, 2013, and over the history we have for it it has risen 31.6%. The table below summarizes its recorded NADAC range and movement.

Current price$3.1186 per ML
All-time high$3.1186 (Dec 12, 2018)
All-time low$2.3689 (Nov 28, 2013)
Median price$2.8073
Average price$2.7693
Largest weekly change+6.9% (Jan 6, 2016)
Weeks tracked264
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+31.6%

Last surveyed Dec 12, 2018 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lopinavir and Ritonavir market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TEGRETOL 100 MG/5 ML SUSP
Brand
00078050883•Novartis Pharmaceuticals Corporation
$0.4370
per ML
TIAZAC ER 180 MG CAPSULE
Brand
00187261330•Bausch Health US LLC
$1.5060
per EA
TIAZAC ER 180 MG CAPSULE
Brand
00187261390•Bausch Health US LLC
$1.5060
per EA
TEGRETOL XR 100 MG TABLET
Brand
00078051005•Novartis Pharmaceuticals Corporation
$1.6273
per EA
CARBATROL ER 200 MG CAPSULE
Brand
54092017212•Takeda Pharmaceuticals America, Inc.
$1.6940
per EA
CARBATROL ER 300 MG CAPSULE
Brand
54092017312•Takeda Pharmaceuticals America, Inc.
$1.6952
per EA
CARBATROL ER 100 MG CAPSULE
Brand
54092017112•Takeda Pharmaceuticals America, Inc.
$1.6996
per EA
MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2069
per ML
ZONISADE 100 MG/5 ML ORAL SUSP
Brand
52652800101•Azurity Pharmaceuticals Inc.
$2.7505
per ML
TIAZAC ER 360 MG CAPSULE
Brand
00187261630•Bausch Health US LLC
$2.7628
per EA

Frequently asked questions

What is the NADAC price of KALETRA 80 MG-20 MG/ML SOLN?

The current National Average Drug Acquisition Cost (NADAC) for KALETRA 80 MG-20 MG/ML SOLN, manufactured by AbbVie Inc., is $3.1186 per ML (NDC 00074395646), effective Dec 12, 2018.

How has the price of KALETRA 80 MG-20 MG/ML SOLN changed over time?

Over the history we have for it, the NADAC for KALETRA 80 MG-20 MG/ML SOLN has risen 31.6%. It has been tracked across 264 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for KALETRA 80 MG-20 MG/ML SOLN?

Since Nov 28, 2013, the NADAC for KALETRA 80 MG-20 MG/ML SOLN has ranged from a low of $2.3689 (Nov 28, 2013) to a high of $3.1186 (Dec 12, 2018), with a median of $2.8073 per ML.

Are there cheaper alternatives to KALETRA 80 MG-20 MG/ML SOLN?

No other NADAC-published product currently shares the active ingredient and strength of KALETRA 80 MG-20 MG/ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures KALETRA 80 MG-20 MG/ML SOLN?

KALETRA 80 MG-20 MG/ML SOLN (NDC 00074395646) is labeled by AbbVie Inc., and CMS classifies it as a brand product.